REGULATED PRESS RELEASE published on 04/29/2025 at 14:58, 8 months 14 days ago GUILLEMOT CORPORATION: Availability of the universal registration document including the 2024 annual financial report Guillemot Corporation S.A. announces availability of 2024 Universal Registration Document. Includes annual financial report, corporate governance report, share buyback program details Share Buyback Program Financial Report Guillemot Corporation Interactive Entertainment 2024 Universal Registration Document
REGULATED PRESS RELEASE published on 04/29/2025 at 14:58, 8 months 14 days ago GUILLEMOT CORPORATION : Mise à disposition du document d’enregistrement universel incluant le rapport financier annuel 2024 Guillemot Corporation S.A. annonce la mise \u00E0 disposition de son Document d'enregistrement universel 2024, incluant rapport financier et programme rachat d'actions AMF Guillemot Corporation Rapport Financier Document D'Enregistrement Universel Programme De Rachat D'actions
PRESS RELEASE published on 04/29/2025 at 14:43, 8 months 14 days ago Petrofac Limited: PUBLICATION OF PROSPECTUS Petrofac Limited announces publication of Prospectus for new shares and warrants on the London Stock Exchange, following approval by the Financial Conduct Authority London Stock Exchange New Shares Financial Conduct Authority Prospectus Petrofac Limited
PRESS RELEASE published on 04/29/2025 at 14:30, 8 months 14 days ago Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation Aspire Biopharma achieves IRB approval for Phase I clinical trial of fast-acting high-dose aspirin formulation, targeting rapid drug delivery and enhanced bioavailability for suspected acute myocardial infarction treatment Phase I Clinical Trial IRB Approval Aspire Biopharma Acute Myocardial Infarction Fast-acting Aspirin
PRESS RELEASE published on 04/29/2025 at 14:30, 8 months 14 days ago Amaze Expands Creator Ecosystem Through Exclusive Partnership with Live Current Media Amaze Holdings announces exclusive deal to operate Live Current Media software, enhancing live streaming capabilities for creators to connect with fans in real time and monetize their communities Live Streaming Amaze Holdings Creator-powered Commerce Live Current Media Exclusive Deal
PRESS RELEASE published on 04/29/2025 at 14:19, 8 months 14 days ago Anemoi International Ltd: Notice of AGM Anemoi International Ltd has announced the Notice of AGM on 11 June 2025 in Eze, France. Shareholders are encouraged to participate and vote Shareholders Financial Statements Notice Of AGM Voting Anemoi International Ltd
PRESS RELEASE published on 04/29/2025 at 14:19, 8 months 14 days ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de la société ARKEMA par BlackRock Inc. pour le compte de clients et de fonds. Détention de 3 746 595 actions représentant 4,93% du capital Déclaration Franchissement De Seuil BlackRock Inc. 5% Du Capital ARKEMA
PRESS RELEASE published on 04/29/2025 at 14:18, 8 months 14 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invesco Ltd. pour VERALLIA. Baisse des seuils de 10% du capital et 5% des droits de vote. Détention de 838 103 actions soit 0,69% du capital et 0,58% des droits de vote Déclaration Franchissement De Seuils Cession D'actions Invesco Ltd. Verallia
PRESS RELEASE published on 04/29/2025 at 14:06, 8 months 14 days ago Anemoi International Ltd: Annual Financial Report to 31 December 2024 Anemoi International Ltd announces its 2024 audited financial results. Despite cost cuts, performance fell short with a loss before taxation. Chairman's statement and future cost reduction plans outlined Revenue Anemoi International Ltd Audited Financial Results Cost Cuts Loss Before Taxation
PRESS RELEASE published on 04/29/2025 at 14:01, 8 months 14 days ago Mainz Biomed Enters into Technology Partnership with EDX Medical Group Mainz BioMed partners with EDX Medical Group for cancer diagnostic technology. Mainz offers molecular diagnostic expertise to enhance early cancer detection services in the UK Technology Partnership Mainz Biomed Molecular Diagnostics Cancer Detection EDX Medical Group
Published on 01/14/2026 at 08:05, 4 hours 7 minutes ago Tocvan Strengthens Board with Appointment of Anna Ladd-Kruger
Published on 01/14/2026 at 08:00, 4 hours 12 minutes ago Caledonia Mining Corporation Plc Change in Executive Management
Published on 01/14/2026 at 04:05, 8 hours 7 minutes ago Usha Resources and Totec Resources Announce TSXV Conditional Acceptance and Filing of Filing Statement for Qualifying Transaction
Published on 01/14/2026 at 12:05, 7 minutes ago EUROPE'S 50 BEST BARS ANNOUNCES ACADEMY CHAIRS AND SPECIAL AWARD CATEGORIES FOR THE LAUNCH EDITION
Published on 01/14/2026 at 12:00, 12 minutes ago Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes
Published on 01/14/2026 at 11:34, 37 minutes ago Sartorius expands bio-circular product offering for more sustainable bioprocesses
Published on 01/14/2026 at 11:06, 1 hour 6 minutes ago LAIQON AG enters 2026 with strengthened management team
Published on 01/14/2026 at 10:26, 1 hour 45 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 01/14/2026 at 08:45, 3 hours 27 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st 2026
Published on 01/14/2026 at 08:45, 3 hours 27 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st, 2026
Published on 01/14/2026 at 08:45, 3 hours 27 minutes ago Arnaud Lagardère est nommé Président non exécutif de Lagardère Travel Retail. Frédéric Chevalier succède à Dag Rasmussen à compter du 1er mars 2026.
Published on 01/13/2026 at 18:27, 17 hours 44 minutes ago 260113 BENETEAU Déclaration du nombre d'actions et de droits de vote au 31-12-2025